Skip to main content
Journal cover image

The effect of reducing posttraumatic stress disorder symptoms on cardiovascular risk: Design and methodology of a randomized clinical trial.

Publication ,  Journal Article
LoSavio, ST; Beckham, JC; Wells, SY; Resick, PA; Sherwood, A; Coffman, CJ; Kirby, AC; Beaver, TA; Dennis, MF; Watkins, LL
Published in: Contemp Clin Trials
March 2021

Posttraumatic stress disorder (PTSD) has been associated with accelerated progression of coronary heart disease (CHD). However, the underlying pathophysiological pathway has remained elusive and it is unclear whether there is a direct link between PTSD and CHD risk. This paper describes the methods of a randomized controlled trial developed to examine how changes in PTSD symptoms affect CHD disease pathways. One hundred twenty participants with current PTSD and who are free of known CHD will be randomized to receive either an evidence-based treatment for PTSD (Cognitive Processing Therapy; CPT) or a waitlist control (WL). Before and after CPT/WL, participants undergo assessment of CHD risk biomarkers reflecting autonomic nervous system dysregulation, systemic inflammation, and vascular endothelial dysfunction. The primary hypothesis is that individuals who show improvement in PTSD symptoms will show improvement in CHD risk biomarkers, whereas individuals who fail to improve or show worsening PTSD symptoms will have no change or worsening in CHD biomarkers. This study is expected to provide knowledge of the role of both the direct impact of PTSD symptoms on CHD risk pathways and the role of these systems as candidate mechanisms underlying the relationship between PTSD and CHD risk. Further, results will provide guidance on the utility of cognitive therapy as a tool to mitigate the accelerated progression of CHD in PTSD. Clinical Trials Registration: https://clinicaltrials.gov/ct2/show/NCT02736929; Unique identifier: NCT02736929.

Duke Scholars

Published In

Contemp Clin Trials

DOI

EISSN

1559-2030

Publication Date

March 2021

Volume

102

Start / End Page

106269

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Stress Disorders, Post-Traumatic
  • Risk Factors
  • Public Health
  • Humans
  • Heart Disease Risk Factors
  • General Clinical Medicine
  • Cognitive Behavioral Therapy
  • Cardiovascular Diseases
  • 42 Health sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
LoSavio, S. T., Beckham, J. C., Wells, S. Y., Resick, P. A., Sherwood, A., Coffman, C. J., … Watkins, L. L. (2021). The effect of reducing posttraumatic stress disorder symptoms on cardiovascular risk: Design and methodology of a randomized clinical trial. Contemp Clin Trials, 102, 106269. https://doi.org/10.1016/j.cct.2021.106269
LoSavio, Stefanie T., Jean C. Beckham, Stephanie Y. Wells, Patricia A. Resick, Andrew Sherwood, Cynthia J. Coffman, Angela C. Kirby, Tiffany A. Beaver, Michelle F. Dennis, and Lana L. Watkins. “The effect of reducing posttraumatic stress disorder symptoms on cardiovascular risk: Design and methodology of a randomized clinical trial.Contemp Clin Trials 102 (March 2021): 106269. https://doi.org/10.1016/j.cct.2021.106269.
LoSavio ST, Beckham JC, Wells SY, Resick PA, Sherwood A, Coffman CJ, et al. The effect of reducing posttraumatic stress disorder symptoms on cardiovascular risk: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2021 Mar;102:106269.
LoSavio, Stefanie T., et al. “The effect of reducing posttraumatic stress disorder symptoms on cardiovascular risk: Design and methodology of a randomized clinical trial.Contemp Clin Trials, vol. 102, Mar. 2021, p. 106269. Pubmed, doi:10.1016/j.cct.2021.106269.
LoSavio ST, Beckham JC, Wells SY, Resick PA, Sherwood A, Coffman CJ, Kirby AC, Beaver TA, Dennis MF, Watkins LL. The effect of reducing posttraumatic stress disorder symptoms on cardiovascular risk: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2021 Mar;102:106269.
Journal cover image

Published In

Contemp Clin Trials

DOI

EISSN

1559-2030

Publication Date

March 2021

Volume

102

Start / End Page

106269

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Stress Disorders, Post-Traumatic
  • Risk Factors
  • Public Health
  • Humans
  • Heart Disease Risk Factors
  • General Clinical Medicine
  • Cognitive Behavioral Therapy
  • Cardiovascular Diseases
  • 42 Health sciences